A Mateus1, D C Brodbelt, N Barber, K D C Stärk. 1. Department of Veterinary Clinical Sciences, Royal Veterinary College, Hawkshead Campus, North Mymms, Hertfordshire AL9 7TA School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX.
Abstract
OBJECTIVES: To provide baseline data on patterns of antimicrobial usage in dogs and cats through the analysis of data stored in electronic practice management systems. METHODS: Clinical data from 11 first opinion veterinary practices were extracted for the year 2007. Descriptive statistical analysis was performed to assess the usage of antimicrobials. RESULTS: Widespread usage of systemic broad-spectrum antimicrobials was observed. Antimicrobials most frequently used in both species were potentiated amoxicillin (44·4% and 46.1% in cats and dogs, respectively) and amoxicillin (14·3% and 20·7%). Cephalexin (13·4%) and cefovecin (15·0%) were also commonly used in dogs and cats, respectively. Systemic critically important antimicrobials in human medicine were widely used in dogs (60·5%) and cats (82·7%). Topical antimicrobials used in both species included fusidic acid (48·4% and 54·8%), framycetin (20·4% and 13·4%), polymyxin B (12·6% and 9·3%) and neomycin (6·5% and 6·6%). CLINICAL SIGNIFICANCE: Inappropriate usage of broad-spectrum antimicrobials may contribute to the development of antimicrobial resistance and loss of efficacy of antimicrobials in veterinary settings. Data recorded in practice management systems were demonstrated to be a practical source for monitoring antimicrobial usage in pets.
OBJECTIVES: To provide baseline data on patterns of antimicrobial usage in dogs and cats through the analysis of data stored in electronic practice management systems. METHODS: Clinical data from 11 first opinion veterinary practices were extracted for the year 2007. Descriptive statistical analysis was performed to assess the usage of antimicrobials. RESULTS: Widespread usage of systemic broad-spectrum antimicrobials was observed. Antimicrobials most frequently used in both species were potentiated amoxicillin (44·4% and 46.1% in cats and dogs, respectively) and amoxicillin (14·3% and 20·7%). Cephalexin (13·4%) and cefovecin (15·0%) were also commonly used in dogs and cats, respectively. Systemic critically important antimicrobials in human medicine were widely used in dogs (60·5%) and cats (82·7%). Topical antimicrobials used in both species included fusidic acid (48·4% and 54·8%), framycetin (20·4% and 13·4%), polymyxin B (12·6% and 9·3%) and neomycin (6·5% and 6·6%). CLINICAL SIGNIFICANCE: Inappropriate usage of broad-spectrum antimicrobials may contribute to the development of antimicrobial resistance and loss of efficacy of antimicrobials in veterinary settings. Data recorded in practice management systems were demonstrated to be a practical source for monitoring antimicrobial usage in pets.
Authors: Petra Muellner; Ulrich Muellner; M Carolyn Gates; Trish Pearce; Christina Ahlstrom; Dan O'Neill; Dave Brodbelt; Nick John Cave Journal: Front Vet Sci Date: 2016-12-23
Authors: D A Singleton; F Sánchez-Vizcaíno; S Dawson; P H Jones; P J M Noble; G L Pinchbeck; N J Williams; A D Radford Journal: Vet J Date: 2017-05-03 Impact factor: 2.688
Authors: L Y Hardefeldt; S Holloway; D J Trott; M Shipstone; V R Barrs; R Malik; M Burrows; S Armstrong; G F Browning; M Stevenson Journal: J Vet Intern Med Date: 2017-05-17 Impact factor: 3.333
Authors: D A Singleton; F Sánchez-Vizcaíno; E Arsevska; S Dawson; P H Jones; P J M Noble; G L Pinchbeck; N J Williams; A D Radford Journal: Prev Vet Med Date: 2018-09-08 Impact factor: 2.670
Authors: Dylan N Clements; Ian G Handel; Erica Rose; Damon Querry; Carys A Pugh; William Er Ollier; Kenton L Morgan; Lorna J Kennedy; Jeffery Sampson; Kim M Summers; B Mark C de Bronsvoort Journal: BMC Vet Res Date: 2013-01-18 Impact factor: 2.741
Authors: Ewan M Harrison; Lucy A Weinert; Matthew T G Holden; John J Welch; Katherine Wilson; Fiona J E Morgan; Simon R Harris; Anette Loeffler; Amanda K Boag; Sharon J Peacock; Gavin K Paterson; Andrew S Waller; Julian Parkhill; Mark A Holmes Journal: mBio Date: 2014-05-13 Impact factor: 7.867